Sex and Gender: Critical Variables in Pre-Clinical and Clinical Medical Research

Cell Metabolism

Volumn 24, Issue 2, 2016, Pages 203-209

  Morselli, Eugenia ^a   Frank, Aaron P ^b   Santos, Roberta S ^c   Fátima, Luciana A ^d   Palmer, Biff F ^e   Clegg, Deborah J ^b  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b Cedars Sinai Diabetes and Obesity Research Institute   (Canada)

^c UNIVERSITY OF CAMPINAS   (Brazil)

^d UNIVERSITY OF SÃO PAULO   (Brazil)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cardiovascular diseases; chromosome; estrogens; gender; obesity; sex; testosterone; type 2 diabetes

Indexed keywords

ANDROSTENEDIONE; ESTRADIOL; ESTROGEN; ESTRONE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SEX HORMONE; TESTOSTERONE; HORMONE;

47,XXX SYNDROME; ANEUPLOIDY; AROMATIZATION; AWARENESS; BEHAVIOR; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; CHROMOSOME; CHROMOSOME ABERRATION; CLINICAL RESEARCH; DROSOPHILA MELANOGASTER; EARLY MENOPAUSE; ESTROGEN THERAPY; GENDER; GENE EXPRESSION; GENETIC DIFFERENCE; HIGH RISK BEHAVIOR; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HORMONE SYNTHESIS; HUMAN; HYPOGONADISM; INSULIN RESISTANCE; INTESTINE EPITHELIUM; ISCHEMIC HEART DISEASE; KLINEFELTER SYNDROME; KNOWLEDGE; MEDICAL LITERATURE; MEDICAL RESEARCH; MENOPAUSE; METABOLIC SYNDROME X; NONHUMAN; NOTE; OBESITY; PERSONALIZED MEDICINE; POSTMENOPAUSE; PRECLINICAL STUDY; PREMATURE OVARIAN FAILURE; PREVALENCE; PRIORITY JOURNAL; SECONDARY PREVENTION; SEX; SEX CHROMOSOME; SEX CHROMOSOME ABERRATION; SEX DIFFERENCE; SEX DIFFERENTIATION; SEX REASSIGNMENT; SEXUAL DEVELOPMENT; SEXUAL FUNCTION; SOCIAL BEHAVIOR; SPERMATOGENESIS; TESTIS DEVELOPMENT; TRANSGENDER; TURNER SYNDROME; X CHROMOSOME; Y CHROMOSOME; DISEASES; EVOLUTION; FEMALE; MALE; RISK FACTOR;

BIOLOGICAL EVOLUTION; DISEASE; FEMALE; HORMONES; HUMANS; MALE; RISK FACTORS; SEX CHARACTERISTICS; SEX FACTORS;

EID: 84991107024     PISSN: 15504131     EISSN: 19327420     Source Type: Journal    
DOI: 10.1016/j.cmet.2016.07.017     Document Type: Note

References (69)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 2013, American Psychiatric Publishing, Arlington, VA.
2. Arnold, A.P., Mouse models for evaluating sex chromosome effects that cause sex differences in non-gonadal tissues. J. Neuroendocrinol. 21 (2009), 377–386.
3. Arnold, A.P., Promoting the understanding of sex differences to enhance equity and excellence in biomedical science. Biol. Sex Differ., 1, 2010, 1.
4. Arnold, A.P., Burgoyne, P.S., Are XX and XY brain cells intrinsically different?. Trends Endocrinol. Metab. 15 (2004), 6–11.
5. Arnold, A.P., Chen, X., What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues?. Front. Neuroendocrinol. 30 (2009), 1–9.
6. Arnold, A.P., Reue, K., Eghbali, M., Vilain, E., Chen, X., Ghahramani, N., Itoh, Y., Li, J., Link, J.C., Ngun, T., Williams-Burris, S.M., The importance of having two X chromosomes. Philos. Trans. R. Soc. Lond. B Biol. Sci., 371, 2016, 20150113.
7. Barrett-Connor, E., Khaw, K.T., Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study. Circulation 78 (1988), 539–545.
8. Beery, A.K., Zucker, I., Sex bias in neuroscience and biomedical research. Neurosci. Biobehav. Rev. 35 (2011), 565–572.
9. Bekhouche, Y.H.R., Tyson, L.D., Zahidi, S., The Global Gender Gap Report, 2015. 2015, World Economic Forum.
10. Bellott, D.W., Hughes, J.F., Skaletsky, H., Brown, L.G., Pyntikova, T., Cho, T.J., Koutseva, N., Zaghlul, S., Graves, T., Rock, S., et al. Mammalian Y chromosomes retain widely expressed dosage-sensitive regulators. Nature 508 (2014), 494–499.
11. Bhasin, S., Cunningham, G.R., Hayes, F.J., Matsumoto, A.M., Snyder, P.J., Swerdloff, R.S., Montori, V.M., Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 91 (2006), 1995–2010.
12. Bojesen, A., Juul, S., Birkebaek, N., Gravholt, C.H., Increased mortality in Klinefelter syndrome. J. Clin. Endocrinol. Metab. 89 (2004), 3830–3834.
13. California Department of Finance (2016). Projections of Populations and Births. http://www.dof.ca.gov/research/demographic/reports/projections/view.php.
14. Canadian Institutes of Health Research (2015). Sex, Gender and Health Research Guide: A Tool for CIHR Applicants. http://www.cihr-irsc.gc.ca/e/32019.html.
15. Carani, C., Qin, K., Simoni, M., Faustini-Fustini, M., Serpente, S., Boyd, J., Korach, K.S., Simpson, E.R., Effect of testosterone and estradiol in a man with aromatase deficiency. N. Engl. J. Med. 337 (1997), 91–95.
16. Charchar, F.J., Bloomer, L.D., Barnes, T.A., Cowley, M.J., Nelson, C.P., Wang, Y., Denniff, M., Debiec, R., Christofidou, P., Nankervis, S., et al. Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet 379 (2012), 915–922.
17. Chen, X., Watkins, R., Delot, E., Reliene, R., Schiestl, R.H., Burgoyne, P.S., Arnold, A.P., Sex difference in neural tube defects in p53-null mice is caused by differences in the complement of X not Y genes. Dev. Neurobiol. 68 (2008), 265–273.
18. Collins, P., Stevenson, J.C., Mosca, L., Spotlight on gender. Cardiovasc. Res. 53 (2002), 535–537.
19. Conron, K.J., Scott, G., Stowell, G.S., Landers, S.J., Transgender health in Massachusetts: results from a household probability sample of adults. Am. J. Public Health 102 (2012), 118–122.
20. Cooper, G.S., Sandler, D.P., Age at natural menopause and mortality. Ann. Epidemiol. 8 (1998), 229–235.
21. Dai, W., Li, Y., Zheng, H., Estradiol/Testosterone imbalance: impact on coronary heart disease risk factors in postmenopausal women. Cardiology 121 (2012), 249–254.
22. De Vries, G.J., Rissman, E.F., Simerly, R.B., Yang, L.Y., Scordalakes, E.M., Auger, C.J., Swain, A., Lovell-Badge, R., Burgoyne, P.S., Arnold, A.P., A model system for study of sex chromosome effects on sexually dimorphic neural and behavioral traits. J. Neurosci. 22 (2002), 9005–9014.
23. Deng, X., Berletch, J.B., Nguyen, D.K., Disteche, C.M., X chromosome regulation: diverse patterns in development, tissues and disease. Nat. Rev. Genet. 15 (2014), 367–378.
24. Dokras, A., Cardiovascular disease risk in women with PCOS. Steroids 78 (2013), 773–776.
25. Finkelstein, J.S., Lee, H., Burnett-Bowie, S.A., Pallais, J.C., Yu, E.W., Borges, L.F., Jones, B.F., Barry, C.V., Wulczyn, K.E., Thomas, B.J., Leder, B.Z., Gonadal steroids and body composition, strength, and sexual function in men. N. Engl. J. Med. 369 (2013), 1011–1022.
26. Firtser, S., Juonala, M., Magnussen, C.G., Jula, A., Loo, B.M., Marniemi, J., Viikari, J.S., Toppari, J., Perheentupa, A., Hutri-Kähönen, N., Raitakari, O.T., Relation of total and free testosterone and sex hormone-binding globulin with cardiovascular risk factors in men aged 24-45 years. The Cardiovascular Risk in Young Finns Study. Atherosclerosis 222 (2012), 257–262.
27. Gates, G.J., How Many People Are Lesbian, Gay, Bisexual, and Transgender?. 2011, The Williams Institute http://williamsinstitute.law.ucla.edu/wp-content/uploads/Gates-How-Many-People-LGBT-Apr-2011.pdf.
28. Gong, Y., Xiao, H., Li, C., Bai, J., Cheng, X., Jin, M., Sun, B., Lu, Y., Shao, Y., Tian, H., Elevated t/e2 ratio is associated with an increased risk of cerebrovascular disease in elderly men. PLoS ONE, 8, 2013, e61598.
29. Gooren, L.J., Kreukels, B., Lapauw, B., Giltay, E.J., (Patho)physiology of cross-sex hormone administration to transsexual people: the potential impact of male-female genetic differences. Andrologia 47 (2015), 5–19.
30. Hassold, T., Hunt, P., To err (meiotically) is human: the genesis of human aneuploidy. Nat. Rev. Genet. 2 (2001), 280–291.
31. Hausmann, R., Tyson, Laura D., Zahidi, S., The Global Gender Gap Report, 2012. 2012, World Economic Forum.
32. Hembree, W.C., Cohen-Kettenis, P., Delemarre-van de Waal, H.A., Gooren, L.J., Meyer, W.J. 3rd, Spack, N.P., Tangpricha, V., Montori, V.M., Endocrine Society. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 94 (2009), 3132–3154.
33. Hodis, H.N., Mack, W.J., Henderson, V.W., Shoupe, D., Budoff, M.J., Hwang-Levine, J., Li, Y., Feng, M., Dustin, L., Kono, N., et al., ELITE Research Group. Vascular effects of early versus late postmenopausal treatment with estradiol. N. Engl. J. Med. 374 (2016), 1221–1231.
34. Hook, E.B., Warburton, D., The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism. Hum. Genet. 64 (1983), 24–27.
35. Hudry, B., Khadayate, S., Miguel-Aliaga, I., The sexual identity of adult intestinal stem cells controls organ size and plasticity. Nature 530 (2016), 344–348.
36. Institute of Medicine Board on Population and Public Health. The National Academies Collection: reports funded by National Institutes of Health. Sex-Specific Reporting of Scientific Research: A Workshop Summary, 2012, National Academies Press National Academy of Sciences, Washington, D.C.
37. Institute of Medicine Forum on Neuroscience and Nervous System Disorders. The National Academies Collection: reports funded by National Institutes of Health. Sex Differences and Implications for Translational Neuroscience Research: Workshop Summary, 2011, National Academies Press, Washington, D.C.
38. Izadnegahdar, M., Singer, J., Lee, M.K., Gao, M., Thompson, C.R., Kopec, J., Humphries, K.H., Do younger women fare worse? Sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years. J. Womens Health 23 (2014), 10–17.
39. Jacobsen, B.K., Nilssen, S., Heuch, I., Kvåle, G., Does age at natural menopause affect mortality from ischemic heart disease?. J. Clin. Epidemiol. 50 (1997), 475–479.
40. Jankowska, E.A., Rozentryt, P., Ponikowska, B., Hartmann, O., Kustrzycka-Kratochwil, D., Reczuch, K., Nowak, J., Borodulin-Nadzieja, L., Polonski, L., Banasiak, W., et al. Circulating estradiol and mortality in men with systolic chronic heart failure. JAMA 301 (2009), 1892–1901.
41. Kannel, W.B., Wilson, P.W., Risk factors that attenuate the female coronary disease advantage. Arch. Intern. Med. 155 (1995), 57–61.
42. Kauth, M.R., Shipherd, J.C., Lindsay, J., Blosnich, J.R., Brown, G.R., Jones, K.T., Access to care for transgender veterans in the Veterans Health Administration: 2006-2013. Am. J. Public Health 104:Suppl 4 (2014), S532–S534.
43. Kawase, K., Kwong, A., Yorozuya, K., Tomizawa, Y., Numann, P.J., Sanfey, H., The attitude and perceptions of work-life balance: a comparison among women surgeons in Japan, USA, and Hong Kong China. World J. Surg. 37 (2013), 2–11.
44. Klinefelter, H., Reifenstein, E., Albright, F., Syndrome characterized by gynecomastia, aspermatogenesis without A-leydigism, and increased excretion of follicle-stimulating hormone. J. Clin. Endocrinol. Metab. 2 (1942), 615–627.
45. Marshall Graves, J.A., The rise and fall of SRY. Trends Genet. 18 (2002), 259–264.
46. Monks, D.A., Johansen, J.A., Mo, K., Rao, P., Eagleson, B., Yu, Z., Lieberman, A.P., Breedlove, S.M., Jordan, C.L., Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc. Natl. Acad. Sci. USA 104 (2007), 18259–18264.
47. Nielsen, J., Wohlert, M., Sex chromosome abnormalities found among 34,910 newborn children: results from a 13-year incidence study in Arhus, Denmark. Birth Defects Orig. Artic. Ser. 26 (1990), 209–223.
48. Passarge, E., Colour Atlas of Genetics. 1995, Thieme Medical Publishers, New York.
49. Phillips, S.P., Defining and measuring gender: a social determinant of health whose time has come. Int. J. Equity Health, 4, 2005, 11.
50. Phoenix, C.H., Goy, R.W., Gerall, A.A., Young, W.C., Organizing action of prenatally administered testosterone propionate on the tissues mediating mating behavior in the female guinea pig. Endocrinology 65 (1959), 369–382.
51. Reed, B., Rhodes, S., Schofield, P., and Wylie, K. (2009). Gender Variance in the UK: Prevalence, Incidence, Growth, and Geographic Distribution.
52. Ren, J., Kelley, R.O., Cardiac health in women with metabolic syndrome: clinical aspects and pathophysiology. Obesity (Silver Spring) 17 (2009), 1114–1123.
53. Schwarcz, M.D., Frishman, W.H., Testosterone and coronary artery disease. Cardiol. Rev. 18 (2010), 251–257.
54. Skafar, D.F., Xu, R., Morales, J., Ram, J., Sowers, J.R., Clinical review 91: Female sex hormones and cardiovascular disease in women. J. Clin. Endocrinol. Metab. 82 (1997), 3913–3918.
55. Snyder, P.J., Bhasin, S., Cunningham, G.R., Matsumoto, A.M., Stephens-Shields, A.J., Cauley, J.A., Gill, T.M., Barrett-Connor, E., Swerdloff, R.S., Wang, C., et al., Testosterone Trials Investigators. Effects of testosterone treatment in older men. N. Engl. J. Med. 374 (2016), 611–624.
56. Sozzi, F.B., Danzi, G.B., Foco, L., Ferlini, M., Tubaro, M., Galli, M., Celli, P., Mannucci, P.M., Myocardial infarction in the young: a sex-based comparison. Coron. Artery Dis. 18 (2007), 429–431.
57. Swerdlow, A.J., Hermon, C., Jacobs, P.A., Alberman, E., Beral, V., Daker, M., Fordyce, A., Youings, S., Mortality and cancer incidence in persons with numerical sex chromosome abnormalities: a cohort study. Ann. Hum. Genet. 65 (2001), 177–188.
58. The Mayo Clinic (2016a). Klinefelter Syndrome. http://www.mayoclinic.org/diseases-conditions/klinefelter-syndrome/basics/definition/con-20033637.
59. The Mayo Clinic (2016b). Triple X Syndrome. http://www.mayoclinic.org/diseases-conditions/triple-x-syndrome/home/ovc-20164620?p=1.
60. The Mayo Clinic (2016c). Turner Syndrome. http://www.mayoclinic.org/diseases-conditions/turner-syndrome/basics/definition/con-20032572.
61. Tivesten, A., Vandenput, L., Labrie, F., Karlsson, M.K., Ljunggren, O., Mellström, D., Ohlsson, C., Low serum testosterone and estradiol predict mortality in elderly men. J. Clin. Endocrinol. Metab. 94 (2009), 2482–2488.
62. U.S. National Library of Medicine (2016). Your Guide to Understanding Genetic Conditions. https://ghr.nlm.nih.gov/condition/triple-x-syndrome.
63. Wierckx, K., Elaut, E., Declercq, E., Heylens, G., De Cuypere, G., Taes, Y., Kaufman, J.M., T'Sjoen, G., Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. Eur. J. Endocrinol. 169 (2013), 471–478.
64. Wijchers, P.J., Yandim, C., Panousopoulou, E., Ahmad, M., Harker, N., Saveliev, A., Burgoyne, P.S., Festenstein, R., Sexual dimorphism in mammalian autosomal gene regulation is determined not only by Sry but by sex chromosome complement as well. Dev. Cell 19 (2010), 477–484.
65. Wintermantel, T.M., Campbell, R.E., Porteous, R., Bock, D., Gröne, H.J., Todman, M.G., Korach, K.S., Greiner, E., Pérez, C.A., Schütz, G., Herbison, A.E., Definition of estrogen receptor pathway critical for estrogen positive feedback to gonadotropin-releasing hormone neurons and fertility. Neuron 52 (2006), 271–280.
66. Wise, A.L., Gyi, L., Manolio, T.A., eXclusion: toward integrating the X chromosome in genome-wide association analyses. Am. J. Hum. Genet. 92 (2013), 643–647.
67. Woodruff, T.K., Kibbe, M.R., Paller, A.S., Turek, F.W., Woolley, C.S., Commentary: “Leaning in” to support sex differences in basic science and clinical research. Endocrinology 155 (2014), 1181–1183.
68. Wu, H., Luo, J., Yu, H., Rattner, A., Mo, A., Wang, Y., Smallwood, P.M., Erlanger, B., Wheelan, S.J., Nathans, J., Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease. Neuron 81 (2014), 103–119.
69. Yanes, L.L., Reckelhoff, J.F., Postmenopausal hypertension. Am. J. Hypertens. 24 (2011), 740–749.